Cargando…

The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel

Human epidermal growth factor 2 (HER2) positivity rates for gastric or gastroesophageal junction (GEJ) adenocarcinoma have been reported at 15–25%. Cyclin D1 (BCL1) is a non-specific proliferative marker. The prognostic significance of HER2 and cyclin D1 is inconclusive, with contradictory data. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	BAR-SELA, GIL, HERSHKOVITZ, DOV, HAIM, NISSIM, KAIDAR-PERSON, ORIT, SHULMAN, KATERINA, BEN-IZHAK, OFER
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573138/ https://www.ncbi.nlm.nih.gov/pubmed/23420289 http://dx.doi.org/10.3892/ol.2012.1031

Ejemplares similares

Suspected CNS Metastases of Askin's Tumor: Would You Irradiate the Neural Axis?
por: Kaidar-Person, Orit, et al.
Publicado: (2012)

Vulvar Cancer in the North of Israel
por: Kaidar-Person, Orit, et al.
Publicado: (2014)

Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021)

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma
por: Sigrand, Julie, et al.
Publicado: (2016)

Lymphoepithelioma-Like Carcinoma of the Salivary Gland: Is Radiotherapy Alone Adequate?
por: Kaidar-Person, Orit, et al.
Publicado: (2011)

Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy
por: Asor, Eyal, et al.
Publicado: (2017)

Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas
por: Nielsen, Sofie L., et al.
Publicado: (2017)

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
por: Van Cutsem, Eric, et al.
Publicado: (2014)

Team Work: Mastectomy, Reconstruction, and Radiation
por: Kaidar-Person, Orit, et al.
Publicado: (2017)

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction
por: Ecker, Brett L., et al.
Publicado: (2016)

The Clinical Significance of Ependymal Enhancement at Presentation in Patients with Malignant Glioma
por: Kaidar-Person, Orit, et al.
Publicado: (2015)

COVID-RO study: the radiation oncology practice at times of COVID-19 outbreak — international survey
por: Appel, Sarit, et al.
Publicado: (2021)

Hippocampal‐sparing whole‐brain radiotherapy using the Elekta equipment
por: Nevelsky, Alexander, et al.
Publicado: (2013)

Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas
por: Simon, Einav, et al.
Publicado: (2017)

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
por: Lago, Nieves Martínez, et al.
Publicado: (2020)

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
por: Esen, Selin Aktürk, et al.
Publicado: (2022)

HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study
por: Huang, Dan, et al.
Publicado: (2013)

Brain Metastasis of Nasopharyngeal Carcinoma: A Case Report and Literature Review
por: Kaidar-Person, Orit, et al.
Publicado: (2012)

Correlation between incidental FDG PET/CT colorectal observations and endoscopic and histopathological results
por: RAINIS, TOVA, et al.
Publicado: (2014)

Relevance of Position and Movement of the Gastroesophageal Junction in Gastroesophageal Reflux Disease
por: Lee, Yeong Yeh
Publicado: (2013)

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
por: Shan, Ling, et al.
Publicado: (2013)

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
por: Li, Weiling, et al.
Publicado: (2022)

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
por: Radford, Maluki, et al.
Publicado: (2023)

Application of nanotechnology to cancer radiotherapy
por: Mi, Yu, et al.
Publicado: (2016)

Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients
por: Zur, Inbar, et al.
Publicado: (2020)

PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
por: Yokoyama, Daiju, et al.
Publicado: (2021)

Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection
por: Ostrow, Sheli L., et al.
Publicado: (2016)

Ethnic Differences in Environmental Restoration: Arab and Jewish Women in Israel
por: Saadi, Diana, et al.
Publicado: (2021)

HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma
por: HUANG, JUN-XING, et al.
Publicado: (2013)

Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
por: Kirschbrown, Whitney P., et al.
Publicado: (2019)

Gastroesophageal junction adenocarcinoma metastasizing to gingiva
por: Masamatti, Smita S, et al.
Publicado: (2013)

Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
por: Kim, Jin-Jo
Publicado: (2018)

Surgical Treatment of Gastroesophageal Junction Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018)

Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in Circulating Tumor DNA
por: Fahoum, Ibrahim, et al.
Publicado: (2018)

Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib
por: Agbarya, Abed, et al.
Publicado: (2014)

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
por: Peng, Zhi, et al.
Publicado: (2021)

Integrative Oncology in Supportive Cancer Care in Israel
por: Shalom-Sharabi, Ilanit, et al.
Publicado: (2018)

Hormone dependent metastatic salivary gland carcinoma: a case report
por: Agbarya, Abed, et al.
Publicado: (2014)

Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer()
por: Poortmans, Philip M.P., et al.
Publicado: (2019)

Relevance of Position and Movement of the Gastroesophageal Junction in Gastroesophageal Reflux Disease: Author's Reply
por: Hong, Su Jin
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_upuh1fq76ghqvbgmkslg30nf24